Michael B. Maris, MD
AML Specialist
Dr. Maris' current research interests are in further optimizing allogeneic hematopoietic transplantation for patients of all types as well as the development of novel drug and drug regimens for the treatment of the patients with acute myeloid leukemia. Dr. Maris has extensive experience as an investigator in multiple clinical trials and he has expertise in the treatment of patients with acute myeloid leukemia and aggressive lymphomas.
Colorado Blood Cancer Institute: 1721 E 19th Ave Ste. 300, Denver, CO 80218, USA